Wuhan Easy Diagnosis Biomedicine (002932.SZ) announced that the actual repurchase time range for the share repurchase used to maintain the company's value and shareholder rights and interests is from March 27, 2024 to June 17, 2024. The company repurchased a total of 8,349,718 shares of the company through a share repurchase dedicated securities account, accounting for 3.59% of the total share capital of the company, with a highest fill price of 20.98 yuan/share, a lowest fill price of 18.17 yuan/share, and a total payment of 162,914,607.58 yuan (excluding transaction fees) using centralized bidding trading.
明德生物(002932.SZ)：累计耗资1.6亿元回购3.59%股份
Wuhan Easy Diagnosis Biomedicine (002932.SZ): Cumulative expenditure of 160 million yuan to repurchase 3.59% of shares.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.